MetaADEDB 2.0 @ LMMD
mepronizine
(WXKUHMCKBJHZGT-UHFFFAOYSA-N)
Structure
SMILES
CN(CCCN1c2ccccc2Sc2c1cc(cc2)C(=O)C)C.CCCC(COC(=O)N)(COC(=O)N)C
Molecular Formula:
C28H40N4O5S
Molecular Weight:
544.706
Log P:
6.8926
Hydrogen Bond Acceptor:
9
Hydrogen Bond Donor:
2
TPSA:
153.49
CAS Number(s):
51848-48-7
Synonym(s)
1.
mepronizine
External Link(s)
MeSHC021311
PubChem Compound171078
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AcidosisOFFSIDES
2Acute respiratory failureOFFSIDES
3Alanine Aminotransferase IncreasedOFFSIDES
4Alcohol consumptionOFFSIDES
5Alcohol poisoningOFFSIDES
6Alpha 2 globulin increasedOFFSIDES
7Altered state of consciousnessOFFSIDES
8AnoxiaOFFSIDES
9Anticholinergic SyndromeOFFSIDES
10ApathyOFFSIDES
11ApneaOFFSIDES
12AscitesOFFSIDES
13AsphyxiaOFFSIDES
14Aspiration PneumoniaOFFSIDES
15Bacterial test positiveOFFSIDES
16Biliary dilatationOFFSIDES
17Blood creatine phosphokinase increasedOFFSIDES
18Blood lactate dehydrogenase increasedOFFSIDES
19Blood pressure fluctuationOFFSIDES
20Blood sodiumOFFSIDES
21Body TemperatureOFFSIDES
22Body height below normalOFFSIDES
23BradycardiaOFFSIDES
24Bronchopulmonary DysplasiaOFFSIDES
25Cardiomyopathy acuteOFFSIDES
26Cerebral atrophyOFFSIDES
27Chemotherapeutic drug level increasedOFFSIDES
28Choking sensationOFFSIDES
29Cleft PalateOFFSIDES
30ConfabulationOFFSIDES
31Conjunctival depositOFFSIDES
32Creatinine renal clearance decreasedOFFSIDES
33CyanosisOFFSIDES
34Cytolytic hepatitisOFFSIDES
35Cytomegalovirus antibody positiveOFFSIDES
36DehydrationOFFSIDES
37DemyelinationOFFSIDES
38Depressed Level of ConsciousnessOFFSIDES
39DiarrheaOFFSIDES
40DrowsinessOFFSIDES
41Drug abuserOFFSIDES
42Drug withdrawal convulsionsOFFSIDES
43DysmorphismOFFSIDES
44EpilepsyOFFSIDES
45EpistaxisOFFSIDES
46Erythrodermic psoriasisOFFSIDES
47EscharOFFSIDES
48Fatty LiverOFFSIDES
49Fluid replacementOFFSIDES
50Foreign body traumaOFFSIDES
51Gamma-Glutamyltransferase IncreasedOFFSIDES
52Gastrointestinal hypermotilityOFFSIDES
53Gastrointestinal obstructionOFFSIDES
54General physical conditionOFFSIDES
55General physical health deteriorationOFFSIDES
56Glasgow coma scaleOFFSIDES
57GranulocytosisOFFSIDES
58Hepatic necrosisOFFSIDES
59HepatitisOFFSIDES
60Herpes simplex serology positiveOFFSIDES
61HydronephrosisOFFSIDES
62HypospadiasOFFSIDES
63HypoxiaOFFSIDES
64IncontinenceOFFSIDES
65Increased bronchial secretionOFFSIDES
66Intestinal ObstructionOFFSIDES
67Intraocular inflammationOFFSIDES
68Kidney FailureOFFSIDES
69LipaseOFFSIDES
70Low set earsOFFSIDES
71Metabolic acidosisOFFSIDES
72Motor retardationOFFSIDES
73Multiple drug overdoseOFFSIDES
74Multiple drug overdose intentionalOFFSIDES
75Muscle enzymeOFFSIDES
76Muscle hypertrophyOFFSIDES
77MutismOFFSIDES
78MyelitisOFFSIDES
79Myoglobin blood increasedOFFSIDES
80Neuroleptic Malignant SyndromeOFFSIDES
81OligohydramniosOFFSIDES
82OmphalitisOFFSIDES
83Optic NeuropathyOFFSIDES
84Oropharyngeal candidiasisOFFSIDES
85OverdoseOFFSIDES
86Pancreatic CystOFFSIDES
87Pancreatic PseudocystOFFSIDES
88Pancreatic enzymes increasedOFFSIDES
89Prothrombin level decreasedOFFSIDES
90Pulmonary arterial hypertensionOFFSIDES
91Renal cystOFFSIDES
92Respiratory FailureOFFSIDES
93RetrognathiaOFFSIDES
94RhabdomyolysisOFFSIDES
95Secretion dischargeOFFSIDES
96Septic ShockOFFSIDES
97Skeletal injuryOFFSIDES
98Splenic InfarctionOFFSIDES
99Stevens-Johnson SyndromeOFFSIDES
100Subcutaneous noduleOFFSIDES
101SubileusOFFSIDES
102Transaminases increasedOFFSIDES
103Urinary tract infection enterococcalOFFSIDES
104Ventricular hypokinesiaOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.